Skip to main content
About Us
Image Credits
Contributor Info
RSS
Log In
Join
Twitter
E-Alerts
Visit StemJournal
Main menu
About
Image Credits
Contributor Info
E-Alerts
Chapters
Cellular and nuclear reprogramming
Ectoderm specification and differentiation
Endoderm specification and differentiation
Epigenetics
Genomics and proteomics
Germ cell and somatic stem cell biology in reproduction
Manufacturing
Mesoderm specification and differentiation
Niche biology, homing, and migration
Renewal
Stem cell immunology
Therapeutic prospects
Tissue engineering
Protocols
Ectoderm differentiation
Endoderm differentiation
Genome editing
Mesoderm differentiation
Pluripotent stem cells
PSC characterization
PSC genetic stability
Reprogramming
StemLabs
Stem Cell COREdinates
Core Facility Profiles
Boston Children's Hospital Human Neuron Core
Boston University Center for Regenerative Medicine iPSC Core
Columbia Stem Cell Initiative Stem Cell Core Facility
Harvard Stem Cell Institute iPS Core Facility
Stem Cell Protocols
Stem Cell Reagents
Other Resources
News & Profiles
Latest News
Stem Cell Institute Profiles
Journal Stream
Forum
Search form
Search
You are here
Home
Biblio
Author
[
Title
]
Type
Year
Filters:
Author
is
Borate, Uma
[Clear All Filters]
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
V
Zeidan AM
,
Pollyea DA
,
Borate U
,
Vasconcelos A
,
Potluri R
,
Rotter D
,
Kiendrebeogo Z
,
Gaugler L
,
Prebet T
,
Strocchia M
, et al.
Venetoclax plus azacitidine compared with intensive chemotherapy as induction for patients with acute myeloid leukemia: retrospective analysis of an electronic medical record database in the United States.
Ann Hematol. 2023.
PubMed
Google Scholar
N
Koenig KL
,
Borate U
.
New investigational combinations for higher-risk MDS.
Hematology Am Soc Hematol Educ Program. 2022;2022(1):368-374.
PubMed
Google Scholar
I
Bottomly D
,
Long N
,
Schultz AReister
,
Kurtz SE
,
Tognon CE
,
Johnson K
,
Abel M
,
Agarwal A
,
Avaylon S
,
Benton E
, et al.
Integrative analysis of drug response and clinical outcome in acute myeloid leukemia.
Cancer Cell. 2022.
PubMed
Google Scholar
C
Bewersdorf JPhilipp
,
Xie Z
,
Bejar R
,
Borate U
,
Boultwood J
,
Brunner AM
,
Buckstein R
,
Carraway HE
,
Churpek JE
,
Daver NG
, et al.
Current landscape of translational and clinical research in myelodysplastic syndromes/neoplasms (MDS): Proceedings from the 1 International Workshop on MDS (iwMDS) Of the International Consortium for MDS (icMDS).
Blood Rev. 2023:101072.
PubMed
Google Scholar
Stahl M
,
Bewersdorf JPhilipp
,
Xie Z
,
Porta MGiovanni D
,
Komrokji R
,
Xu ML
,
Abdel-Wahab O
,
Taylor J
,
Steensma DP
,
Starczynowski DT
, et al.
Classification, risk stratification and response assessment in myelodysplastic syndromes/neoplasms (MDS): A state-of-the-art report on behalf of the International Consortium for MDS (icMDS).
Blood Rev. 2023:101128.
PubMed
Google Scholar
A
Lachowiez C
,
Cook RJ
,
Hayes-Lattin B
,
Maziarz RT
,
Borate U
,
Traer E
,
Leonard J
,
Newell L
,
Dao K-H
,
Meyers G
.
Allogeneic transplantation outcomes amongst a contemporary cohort of high-risk myelodysplastic syndrome and acute myeloid leukemia patients aged ≥70 years.
Hematol Oncol Stem Cell Ther. 2019.
PubMed
Google Scholar